secwatch.observer — SEC 8-K summary
======================================

Issuer:     Petros Pharmaceuticals, Inc. (PTPI)
CIK:        0001815903
Form:       8-K
Filed at:   2021-12-01T23:59:59+00:00
Accession:  0001104659-21-145529
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Petros Pharmaceuticals raises $10M in registered direct offering and private placement
--------------------------------------------------------------------------------

- Gross proceeds of $10M from sale of 3,333,333 shares at $3.00/share; net proceeds ~$9.3M.
- Issues warrants to purchase 2,500,000 shares at $3.50/share, exercisable for 5 years.
- Largest shareholder among existing investors; Katalyst Securities acted as financial advisor.
- Proceeds to be used for men's health platform expansion and general corporate purposes.
- Closing expected on or about December 2, 2021, subject to customary conditions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1815903/000110465921145529/0001104659-21-145529-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1815903/000110465921145529/tm2134293d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-21-145529

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer